1 |
alpha-actinin-3
(66 times)
|
Sports Medicine (25 times)
|
ACE (21 times) CK (2 times) IL-6 (2 times)
|
1997 Deficiency of alpha-actinin-3 (ACTN3) occurs in different forms of muscular dystrophy.
|
2 |
actinin-3
(8 times)
|
Physiology (3 times)
|
ACE (6 times) AF (1 time) AFL (1 time)
|
2010 ACE I/D and ACTN3 R/X polymorphisms and muscle function and muscularity of older Caucasian men.
|
3 |
alpha-actinin-3 gene
(8 times)
|
Physiology (3 times)
|
ACE (2 times) CIs (1 time) MHC (1 time)
|
2010 Does the ACE I/D polymorphism, alone or in combination with the ACTN3 R577X polymorphism, influence muscle power phenotypes in young, non-athletic adults?
|
4 |
actinin alpha 3
(2 times)
|
Sports Medicine (1 time)
|
ACOX1 (1 time) APOE (1 time) FTO (1 time)
|
2010 Advances in exercise, fitness, and performance genomics.
|
5 |
actinin alpha 3 gene
(1 time)
|
Geriatrics (1 time)
|
FI (1 time)
|
2018 ACTN3 genotype and physical function and frailty in an elderly Chinese population: the Rugao Longevity and Ageing Study.
|
6 |
actinin-3 gene
(1 time)
|
Cell Biology (1 time)
|
ACE (1 time)
|
2018 Prevalence of alpha actinin-3 gene (ACTN3) R577X and angiotensin converting enzyme (ACE) insertion / deletion gene polymorphisms in national and amateur Turkish athletes.
|
7 |
alpha(3)-actinin
(1 time)
|
Physiology (1 time)
|
ADRB2 (1 time) AMPD1 (1 time) APOE (1 time)
|
2010 Associations of polymorphisms of eight muscle- or metabolism-related genes with performance in Mount Olympus marathon runners.
|
8 |
alpha-actinin-3 encoding gene
(1 time)
|
Physiology (1 time)
|
FFM (1 time) KE (1 time)
|
2008 ACTN3 genotype is associated with muscle phenotypes in women across the adult age span.
|
9 |
alpha-actinin-3 R577X
(1 time)
|
Physiology (1 time)
|
ACE (1 time)
|
2015 ACE and ACTN3 genes polymorphisms among female Hungarian athletes in the aspect of sport disciplines.
|
10 |
alpha-actinin3 R577X polymorphism
(1 time)
|
Biochemistry (1 time)
|
ERT (2 times) ACE (1 time) PPARalpha (1 time)
|
2012 Can genes influencing muscle function affect the therapeutic response to enzyme replacement therapy (ERT) in late-onset type II glycogenosis?
|